[
{"cids": "6", "collection": "ClinicalTrials.gov", "collection_code": "clinicaltrials", "conditions": "HIV Infections", "date": "2005-06-24", "diseaseids": "9765", "id": "NCT00002175", "id_url": "https://clinicaltrials.gov/ct2/show/NCT00002175", "interventions": "Dinitrochlorobenzene", "link": "https://clinicaltrials.gov/ct2/show/NCT00002175", "phase": "Phase 1", "status": "Completed", "title": "Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection.", "cid": 6, "smiles": "C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])Cl", "inchikey": "VYZAHLCBVHPDDF-UHFFFAOYSA-N", "iupac_name": "1-chloro-2,4-dinitrobenzene", "compound_error": null, "image_base64": "data:image/png;base64,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"},
{"cids": "6", "collection": "ClinicalTrials.gov", "collection_code": "clinicaltrials", "conditions": "HIV Infections", "date": "2005-06-24", "diseaseids": "9765", "id": "NCT00002031", "id_url": "https://clinicaltrials.gov/ct2/show/NCT00002031", "interventions": "Dinitrochlorobenzene", "link": "https://clinicaltrials.gov/ct2/show/NCT00002031", "phase": "N/A", "status": "Completed", "title": "Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)", "cid": 6, "smiles": "C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])Cl", "inchikey": "VYZAHLCBVHPDDF-UHFFFAOYSA-N", "iupac_name": "1-chloro-2,4-dinitrobenzene", "compound_error": null, "image_base64": "data:image/png;base64,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"},
{"cids": "121892|38|5991", "collection": "ClinicalTrials.gov", "collection_code": "clinicaltrials", "conditions": "Health", "date": "2011-12-07", "id": "NCT01214278", "id_url": "https://clinicaltrials.gov/ct2/show/NCT01214278", "interventions": "KPL", "link": "https://clinicaltrials.gov/ct2/show/NCT01214278", "phase": "Phase 4", "status": "Completed", "title": "Bioavailability of Different n-3 Fatty Acid Formulations", "cid": 38, "smiles": "CC(C)(CO)C(=O)C(=O)O", "inchikey": "PKVVTUWHANFMQC-UHFFFAOYSA-N", "iupac_name": "4-hydroxy-3,3-dimethyl-2-oxobutanoic acid", "compound_error": null, "image_base64": "data:image/png;base64,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"},
{"cids": "164533|51", "collection": "ClinicalTrials.gov", "collection_code": "clinicaltrials", "conditions": "Patients With an Abdominal Aortic Aneurysm of 39-49 mm in Diameter", "date": "2021-02-21", "id": "NCT04723888", "id_url": "https://clinicaltrials.gov/ct2/show/NCT04723888", "interventions": "alpha-ketoglutarate", "link": "https://clinicaltrials.gov/ct2/show/NCT04723888", "phase": "N/A", "status": "Recruiting", "title": "Alpha-Ketoglutarate and Abdominal Aortic Aneurysm Progression and Rupture", "cid": 51, "smiles": "C(CC(=O)O)C(=O)C(=O)O", "inchikey": "KPGXRSRHYNQIFN-UHFFFAOYSA-N", "iupac_name": "2-oxopentanedioic acid", "compound_error": null, "image_base64": "data:image/png;base64,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"},
{"cids": "164533|51", "collection": "ClinicalTrials.gov", "collection_code": "clinicaltrials", "conditions": "CABG", "date": "2025-06-22", "id": "NCT07031128", "id_url": "https://clinicaltrials.gov/ct2/show/NCT07031128", "interventions": "Placebo", "link": "https://clinicaltrials.gov/ct2/show/NCT07031128", "phase": "Phase 4", "status": "Recruiting", "title": "Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS)", "cid": 51, "smiles": "C(CC(=O)O)C(=O)C(=O)O", "inchikey": "KPGXRSRHYNQIFN-UHFFFAOYSA-N", "iupac_name": "2-oxopentanedioic acid", "compound_error": null, "image_base64": "data:image/png;base64,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"},
{"cids": "164533|51", "collection": "ClinicalTrials.gov", "collection_code": "clinicaltrials", "conditions": "Colorectal Cancer", "date": "2024-10-17", "id": "NCT06646809", "id_url": "https://clinicaltrials.gov/ct2/show/NCT06646809", "interventions": "Placebo", "link": "https://clinicaltrials.gov/ct2/show/NCT06646809", "phase": "Phase 3", "status": "Recruiting", "title": "Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial", "cid": 51, "smiles": "C(CC(=O)O)C(=O)C(=O)O", "inchikey": "KPGXRSRHYNQIFN-UHFFFAOYSA-N", "iupac_name": "2-oxopentanedioic acid", "compound_error": null, "image_base64": "data:image/png;base64,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"}
]
